Internal Sample Attenuator Counting (IsAc). A New Technique for Separating and Measuring Bound and Free Activity in Radioimmunoassays
Jan I. Thorell I describe a new method for the separation and counting of bound and free activity in radioimmunoassays. Particles containing a radiation-absorbing (attenuating) material are added to the assay. They shield the radiation from either the antibody-bound or the free radioligand. This obviates such manipulations conventionally involved in the separation and counting steps of radioimmunoassays as centrifugation and decanting. Bismuth oxide is used as the attenuator. Particles with different properties are described. In one type, bismuth oxide is combined with active charcoal in an agarose matrix and serves as an adsorbant for the free radioligand. In another type bismuth oxide is trapped within a polyacrylamide matrix to which antibodies are coupled. This particle can be used with a first-or a second-antibody bound activity. Application of the technique is illustrated with radioimmunoassays for thyroxin, triiodothyronine, human choriogonadotropin, and Iutropin (luteinizing hormone).
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Radioimmunoassay and other radioligand assays are "heterogeneous" in nature, i.e., they require separation of antibody-bound and free ligand before the radioactivity is counted. In most assays this separation involves several steps. Typically, the bound or the free ligand is insolubilized by (e.g.) precipitation or by binding or adsorption to a non-soluble material. Then this material is centrifuged down, and the soluble phase is removed by decanting, suction, etc. These procedures are work intensive, and both the centrifugation and the removal of the supernatant fluid constitute main obstacles for the development of completely automated radioimmunoassay systems. In addition, the separation step is one of the major causes of imprecision of the assays, and it involves some risk of radioactive contamination of the outside of the test tubes.
The separation procedures have been simplified in various ways, in particular by coupling the antibody to solid phases such as microparticles (1), discs (2), or to the inside of the test tubes (3). These methods still require removal of the liquid phase to permit counting of the bound activity. In assays with tritiated ligands the extraction of the free ligand into the liquid scintillator (4,5) makes it possible to count the tubes without further separation of the phases.
An alternative approach is to selectively shield (attenuate) the radiation of the bound or the free radioligand within the test tube. The low-energy y-radiation of 'I (X-rays of 23-35 keV), the most commonly used tracer in radioimmunoassays, penetrates most high-Z materials poorly (6). It would therefore be feasible to attain this effect by including an attenuating Department of Nuclear Medicine, University of Lund at Malm#{246} General Hospital, S-214 01 Malm#{246}, Sweden.
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material as a reagent in the assay. This report describes the development of such an internal sample attenuator counting (IsAc) method and exemplifies its application to some different radioimmunoassays. Gharib et al. (8) . Other first-antibodies were produced by immunization with unconjugated hormones as described in detail previously (9). Precipitating secondantibodies were raised by injection of purified rabbit IgG into goats as described elsewhere (10).
Materials and Methods

Materials
Attenuators. Attenuation of the low-energy photons emitted by 125J is mainly caused by photoelectric interaction. Attenuation is greatest with elements having the absorption edge of the K or L electrons just below 27.2 keV (the lowest energy of 1251 X-rays). Table 1 shows the attenuation characteristics of some elements. Metallic tungsten powder (Wolfram, puriss.; Kebo, Stockholm, Sweden) was used in the initial studies when the physical feasibility of sample attenuators was being investigated. Thereafter, crystallized bismuth oxide (E. Merck AG, Darmstadt, F.R.G.) was used for the production of the attenuator reagents.
Adsorber-attenuator reagent. Particles of agarose containing bismuth oxide and active charcoal were produced to obtain a reagent with both attenuating and adsorbing properties ("charcoal-bismuth particles"). We mixed 40 g of bismuth oxide with 1.5 g of activated charcoal (Aktivkohle zur Analyse, E. Merck AG), added 15 mL of hot agarose (Marine Colloids Div. FMC Corp., Rockland, ME 04841), 20 g/L in the barbital buffer (no albumin), and mixed carefully to wet the material thoroughly. The mixture was left in the refrigerator to gel. The gel was coarsely disintegrated in a mortar, then suspended in 100 mL of barbital buffer containing 2.5 g of bovine serum albumin and 1.5 g of Dextran T 70 (Pharmacia, Uppsala, Sweden) per liter. The suspension was homogenized The horizontal axis gives the concentration of standards. Filled circles are the measured activity. Open circles denote the attenuated antibody-bound activity (total activity minus measured activity). The triangles give the results from a conventional assay with the sternate decanted and the actMty of the precipitate counted. Each tube of the assay contained 0.1 ml of insulin standards, 0.2 mL of guinea pIg anti-insulin serum (1:150 000) and 0.2 ml of 125l-labeled insulin (0.1 ng). After incubation overnight at 4 #{176}C antibodies were precipitated with 0.05 mL of anti-guinea pig igG (1:10) and 0.05 ml of normal guinea pig serum
(1:500). Four hours later, 0.4 g of tungsten powder was added to all tubes. They were centrIfuged at 1700 X gand then another 0. for lOs with a Polytron (Kinematica, Lucerne, Switzerland). Stored at 4 #{176}C, it could be used for several months.
Antibody-attenuator reagent. Particles of polyacrylamide containing bismuth oxide, to which antibodies were coupled with glutaraldehyde, were produced to obtain a solid-phase antibody with attenuation properties ("antibody-bismuth particles").
The particles were made with the emulsion technique of Ekman and Sj#{246}holm (13), with the following modifications.
The water phase consisted of 10 mL of 0. This mixture was slowly rotated overnight at room temperature. The particles were washed repeatedly with phosphate buffer and finally with buffer containing, per liter, 1 mol of NaCl and 0.1 mol of lysine . HC1 to saturate any remaining uncoupled reactive sites. They were then suspended in 10 mL of the barbital-BSA diluent.
Methods
All assays were performed in 11 X 55 mm polystyrene tubes with round bottoms. Radioimmunoassay with adsorber-attenuator separation (applied to a T3-assay).
We incubated 0.05 mL of serum (or standards diluted in charcoal-treated serum), 0. a Charcoal-bismuth particles were made as described in Materials except for variation in the amount of bismuth oxkle (91203)added. b "Leakage" denotes the fraction of the radioactivity contained In the sediment of the adsorber-attenuator method that can be detected in a well counter. 100% is the actIvity detected when the same activity is contained In 0.2 ml of dlluent (the volume of the sediment).
at 4 #{176}C. Then, 1 mL of a suspension containing second-antibody-bismuth particles and 400 mg of bismuth oxide powder were added. The amount of the antibody-bismuth particles was that found, by titration, to bind all of the first antibody. The tubes were rotated for 1 h, then placed on the bench to permit sedimentation. The radioactivity in them was then counted in the well counter.
Results
The principal of internal sample attenuator counting was first tested in some model experiments. Figure 1 shows that the antibody-bound radioactivity in a conventional doubleantibody assay can be effectively shielded within the test tube so that only the activity of the supernate is recorded by the detector. When the antibody-bound activity hidden within the shielded sediment was estimated (total activity added to the tube minus measured activity), the typical standard curve for a competitive assay resulted.
The efficiency with which bismuth oxide attenuates the radioactivity within test tubes is illustrated in Tables Adsorber-attenuator method. The combination of bismuth oxide with charcoal within a matrix of agarose gives a reagent that both adsorbs and attenuates the unbound activity. The high density of the bismuth oxide causes the particles to sediment within 5-10 mm without centrifugation.
Because this method measures the antibody-bound activity in the supernate, it shows the common type of standard curve with upward concavity. Its application to T4 assay is shown in Figure 2 . The results, both for this assay and a similar method for T3, agreed closely with those of our routine T3 and T4 assays (Table 5) . a The charcoal-bismuth particle suspension as described In Materials. b Table 2 , footnote b Table 2 .
Antibody-attenuator methods. Figure  3 illustrates a standard curve from the determination of hCG with the hCG antiserum coupled to the polyacrylamide-bismuth particles. Only 1-5 mg of these particles could be added per tube to obtain proper binding conditions for the assay, because of their high antibody-binding capacity. The additional attenuator material needed was added as crystalline bismuth oxide powder as described in Methods. Figure 4 shows the application of the second-antibody attenuator particles to an LH assay and a comparison with the same assay performed with a conventional double-antibody solid-phase separation of bound and free radioactivity, with decantation of this supernate.
Discussion
Internal sample attenuator counting is a new technique for 
